RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Rima Tawk to Sirolimus

Back to Details
This is a "connection" page, showing publications Rima Tawk has written about Sirolimus.
Rima Tawk
Connection Strength
0.118
Sirolimus
  1. Diaby V, Adunlin G, Ali AA, Tawk R. Using quality-adjusted progression-free survival as an outcome measure to assess the benefits of cancer drugs in randomized-controlled trials: case of the BOLERO-2 trial. Breast Cancer Res Treat. 2014 Aug; 146(3):669-73.
    View in: PubMed
    Score: 0.118
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support